Liver Liquescence
Liver Liquescence is an FDA drug label for the active ingredient CARDUUS MARIANUS, CHELIDONIUM MAJUS, LAPPA MAJOR, UVA URSI, RAPHANUS SATIVUS, TARAXACUM OFFICINALE, LYCOPODIUM CLAVATUM, HYDRASTIS CANADENSIS, GALLBLADDER (BOVINE), HEPAR SUIS, BETA VULGARIS, PHOSPHORUS manufactured by Nutritional Specialties, Inc. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20230912.
- Generic name
- CARDUUS MARIANUS, CHELIDONIUM MAJUS, LAPPA MAJOR, UVA URSI, RAPHANUS SATIVUS, TARAXACUM OFFICINALE, LYCOPODIUM CLAVATUM, HYDRASTIS CANADENSIS, GALLBLADDER (BOVINE), HEPAR SUIS, BETA VULGARIS, PHOSPHORUS
- Manufacturer
- Nutritional Specialties, Inc.
- Product type
- HUMAN OTC DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 83027-0016
- Application
- N/A
- Label effective
- 20230912
Active ingredients
Indications & Usage
INDICATIONS: Provides potentized homeo-nutritional support and drainage for the liver.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Dosage & Administration
DIRECTIONS: Adults 1 to 2 teaspoons one to two times daily. Children under twelve one half adult dosage. Consult a physician for use in children under 12 years of age.
Contraindications
Not available.
Warnings
WARNINGS: Professional Use Only If pregnant or breast-feeding, ask a health professional before use. In case of overdose, get medical help or contact a Poison Control Center right away. If condition worsens, seek medical attention. KEEP OUT OF REACH OF CHILDREN Do not use if tamper evident seal is broken or missing. Store in a cool place after opening
Adverse Reactions
Not available.